Last 137.40
Change Today -3.50 / -2.48%
Volume 15.7K
BICL On Other Exchanges
Symbol
Exchange
BICL is not on other exchanges.
As of 10:24 AM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

biocancell ltd (BICL) Snapshot

Open
$140.90
Previous Close
$140.90
Day High
$148.00
Day Low
$135.50
52 Week High
03/23/14 - $344.70
52 Week Low
11/17/14 - $114.00
Market Cap
41.3M
Average Volume 10 Days
90.0K
EPS TTM
$-1.07
Shares Outstanding
30.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOCANCELL LTD (BICL)

Related News

No related news articles were found.

biocancell ltd (BICL) Related Businessweek News

No Related Businessweek News Found

biocancell ltd (BICL) Details

BioCancell Ltd., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for treating cancer-related diseases. Its lead drug-candidate, BC-819, which has completed Phase IIb clinical trials for the treatment of bladder cancer, as well as additional clinical trials for other cancer indications. The company is also developing BC-821 that is in pre-clinical studies as a treatment for various cancer indications. BioCancell Ltd. was founded in 2004 and is based in Jerusalem, Israel.

8 Employees
Last Reported Date: 04/23/13
Founded in 2004

biocancell ltd (BICL) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: 818.9K
Co-Founder, Chief Scientific Officer and Dire...
Total Annual Compensation: 626.9K
Vice President of Clinical Development
Total Annual Compensation: 719.3K
Compensation as of Fiscal Year 2012.

biocancell ltd (BICL) Key Developments

BioCancell Ltd., Annual General Meeting, Aug 21, 2014

BioCancell Ltd., Annual General Meeting, Aug 21, 2014., at 11:00 Israel Standard Time.

BioCancell Plans To Raise Funds

BioCancell Ltd. (TASE:BICL) is planning to raise ILS 28.8 million through rights issue. The stock is being offered at ILS 2.4 per share.

BioCancell Therapeutics, Inc., Special/Extraordinary Shareholders Meeting, Apr 24, 2014

BioCancell Therapeutics, Inc., Special/Extraordinary Shareholders Meeting, Apr 24, 2014., at 11:00 Israel Standard Time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BICL:IT 137.40 -3.50

BICL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BICL.
View Industry Companies
 

Industry Analysis

BICL

Industry Average

Valuation BICL Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOCANCELL LTD, please visit www.biocancell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.